Blog
RSS FeedPosted by Michael Wonder on 08 Aug 2022
Pear Therapeutics and SelectHealth announce coverage to provide access to FDA authorised prescription digital therapeutic for the treatment of opioid use disorder
8 August 2022 - SelectHealth teams with Pear to provide its members with covered access to Pear’s innovative prescription digital therapeutic, ...
Posted by Michael Wonder on 04 Aug 2022
Pear Therapeutics and Cove Behavioral Health to provide patients access to prescription digital therapeutic for the treatment of opioid use disorder
3 August 2022 - Pear Therapeutics announced today that Cove Behavioral Health will provide access to Pear’s FDA authorised PDT reSET-O ...
Posted by Michael Wonder on 15 May 2022
Digital health devices must prove a benefit to get reimbursement
13 May 2022 - Digital health care companies should prove that their devices can improve the quality of patient care ...
Posted by Michael Wonder on 19 Apr 2022
iHealthScreen announces TGA approval for iPredict automated AI system for early diagnosis of diabetic retinopathy, age-related macular degeneration and glaucoma suspect
19 April 2022 - iHealthScreen is the first company in the USA to receive a CE certification, Australian Health approval, and ...
Posted by Michael Wonder on 13 Apr 2022
Pear Therapeutics receives safer technologies program designation from FDA for product candidate to treat acute and chronic pain
13 April 2022 - Pear Therapeutics today announced it has received safer technologies program for medical devices designation from the ...
Posted by Michael Wonder on 04 Apr 2022
Digital Medicine Society launches toolkit to support reimbursement for new drugs developed using digital outcomes
4 April 2022 - New essential resources ensure that patients will benefit without delay following regulatory acceptance of digital outcomes. ...
Posted by Michael Wonder on 30 Mar 2022
FDA officials aim to stop misuse of the term ‘digital biomarker’
29 March 2022 - While a lot of researchers claim they are capturing digital biomarker data, they may in fact be ...
Posted by Michael Wonder on 03 Mar 2022
Digital Therapeutics should be regulated with gold standard evidence
28 February 2022 - There is enormous growth in the digital health sector, illustrated by huge capital investment, and a massive ...
Posted by Michael Wonder on 02 Mar 2022
DynamiCare Health digital therapeutic receives FDA breakthrough device designation for treatment of smoking during pregnancy
23 February 2022 - If approved, DynamiCare’s DCH-001 would become the first prescription treatment for smoking cessation demonstrated to be safe ...
Posted by Michael Wonder on 21 Feb 2022
Apple iPhone game changing new health feature cleared by FDA, coming in weeks
20 February 2022 - A new app is coming this spring which will be game changing for diabetes care. ...
Posted by Michael Wonder on 19 Feb 2022
How digital therapeutics platforms are revolutionising health care delivery
17 February 2022 - With enormous advances in digital health innovation, we are quickly moving into an age where software platforms ...
Posted by Michael Wonder on 13 Feb 2022
How is NICE supporting digital health technology developers?
10 February 2022 - From sensor-enabled glasses that facilitate self-management for major depression to devices that measure muscle performance to ...
Posted by Michael Wonder on 01 Feb 2022
Blue Note Therapeutics receives breakthrough device designation for prescription only digital therapeutic for acute myeloid leukaemia
31 January 2022 - Blue Note Therapeutics, a prescription digital therapeutics company dedicated to easing the burden of cancer and improving ...
Posted by Michael Wonder on 22 Nov 2021
Pear Therapeutics receives FDA breakthrough device designation for prescription digital therapeutic candidate to treat alcohol use disorder
22 November 2021 – Pear Therapeutics today announced that it has received breakthrough device designation from the U.S. FDA for ...
Posted by Michael Wonder on 20 Oct 2021
Luminopia announces FDA approval of digital therapeutic that uses TV shows to improve vision in children with lazy eye
20 October 2021 - Luminopia One improves vision in children with amblyopia, the leading cause of vision loss in children, and ...